There was no difference between the Seprafilm and control group in the overall incidence of SBO (12% vs 12%). However, the incidence of SBO requiring
Milciclib datasheet surgical intervention was significantly lower in the Seprafilm group (1.8% vs 3.4%; P < .05). This was an absolute reduction of 1.6% and a relative reduction of 47%. Stepwise multivariate analysis showed that the use of Seprafilm was the only independent factor for reducing SBO requiring reoperation . Kudo et al in a nonrandomized study of 51 patients who underwent transabdominal aortic aneurysm surgery, analyzed the incidence of early SBO in patients who had Seprafilm applied and in control patients with no treatment. The incidence of early SBO was 0% in the Seprafilm group and 20% in the control group (P < .05) . A dutch RCT including 71 patients requiring a Hartmann procedure for sigmoid diverticulitis or obstructed rectosigmoid were randomized to either intraperitoneal placement of the antiadhesions membrane under the midline during laparotomy and in the pelvis, or as a control . The incidence of adhesions did not differ significantly between the two groups, but the AZD1480 cost severity of adhesions was significantly reduced in the Seprafilm group both for the midline incision and for the pelvic area. Complications occurred in similar numbers in both groups. A recent systematic Review and Meta-analysis
 including 4203 patients showed that incidence of grade 0 adhesions among Seprafilm-treated patients was statistically significantly more than that observed among control group patients. There was no significant difference in the incidence of grade 1 adhesions between Seprafilm and control groups. The severity of grade 2 and grade 3 adhesions among Seprafilm-treated patients
was significantly less than that observed among control group patients. The incidence of intestinal obstruction after abdominal surgery was not different between Seprafilm and control groups. Using Seprafilm significantly increased the incidence of abdominal Luminespib supplier abscesses and anastomotic leaks. In a Cochrane review of 7 RCT, six compared hyaluronic acid/carboxymethyl membrane (HA/CMC) and one 0.5% ferric hyaluronate gel Meloxicam against controls. HA/CMC reduced the incidence of adhesions with reduced extent and severity . However there was no reduction of intestinal obstruction needing surgical intervention with comparable overall morbidity and mortality. The study of 0.5% ferric hyaluronate gel was prematurely terminated and no valid conclusions could be made but there was a higher incidence of overall morbidity and ileus. Therefore authors’ conclusions were that the use of HA/CMC membrane reduces incidence, extent and severity of adhesions which may, theoretically, have implications in re-operative abdominal surgery. There is no evidence that the incidence of intestinal obstruction or need for operative intervention is reduced.